查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1744962

全球主動脈瓣市場

Aortic Valves
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 268 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球主動脈瓣市場將達到 98 億美元

全球主動脈瓣市場規模預計在2024年為61億美元，預計到2030年將達到98億美元，2024年至2030年的複合年成長率為8.2%。機械瓣膜是本報告分析的細分市場之一，預計其複合年成長率為7.1%，到分析期結束時將達到58億美元。生物瓣膜在分析期間內的複合年成長率預計為10.1%。

美國市場規模估計為 17 億美元，中國市場預計複合年成長率為 12.6%

美國主動脈瓣市場規模預計在2024年達到17億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到21億美元，在2024-2030年的分析期間內，複合年成長率為12.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為4.2%和7.8%。在歐洲，預計德國市場的複合年成長率為5.5%。

全球主動脈瓣市場－主要趨勢與促進因素摘要

為什麼主動脈瓣對於治療老化人口結構性心臟病至關重要

主動脈瓣在調節從左心室到主動脈的單向血流中起著至關重要的作用，其功能障礙（通常是狹窄或逆流）會導致嚴重的心臟疾病和死亡。透過外科手術或經導管進行的主動脈瓣置換術術（AVR）已成為老年結構性心臟疾病患者（尤其是退化性瓣膜疾病）的主要治療方法。隨著全球主動脈瓣狹窄負擔的增加和人口老化，主動脈瓣作為恢復心臟功能、緩解症狀和提高生存率的救命植入，正日益受到關注。

歷史上，外科主動脈瓣置換術(SAVR) 曾是標準治療方法，需要在心肺體外迴圈進行開胸手術。然而，微創手術—經導管主動脈瓣置換術(TAVR) 的出現徹底改變了治療模式，擴大了先前被認為無法手術或手術風險高的患者群體的可及性。此後，TAVR 的應用範圍已擴展至中低風險族群，強化了其在更廣泛患者群體中作為第一線治療方案的地位。這項變化源自於積極的臨床試驗數據，這些數據顯示，在合適的患者群體中，TAVR 的療效與 SAVR 相當或更佳。

除狹窄外，主動脈瓣介入治療在二尖瓣疾病、退化生物瓣膜的瓣中瓣手術以及需要多次瓣膜介入治療的複雜瓣膜疾病的治療中也日益受到重視。心臟衰竭、鈣化性瓣膜退化盛行率的上升以及無症狀性患者篩檢的增多，進一步推動了相關手術數量的成長。隨著預期壽命的延長以及心血管疾病仍然是全球衛生重點，主動脈瓣置換術仍然是現代心臟病學的關鍵治療方法。

設備創新和程序技術如何進步以改善瓣膜性能和患者預後？

瓣膜設計的創新提高了手術瓣膜和經導管瓣膜的動態性能、耐用性和可植入性。由牛或豬心包組織製成的生物瓣膜，如今已採用抗鈣化劑處理，並安裝在軟性框架上，以減少免疫反應並延長使用壽命。新一代TAVR系統具有可重新定位和回收功能、更細的輸送導管以及增強的徑向強度，可在高度鈣化或二尖瓣主動脈根部等解剖學困難的病例中實現牢固固定。

術前影像學的進步，尤其是多偵測器CT和3D超音波心臟檢查，使得病患選擇、瓣環大小測定和手術規劃更加精準。影像學與數位導航平台和即時螢光透視引導的結合，最大限度地減少了瓣週漏、血管損傷和傳導障礙。此外，術中創新，例如腦栓塞保護裝置和清醒鎮靜方案，提高了安全性，並縮短了恢復時間。

耐用性仍然是創新的核心，尤其是在年輕、低風險患者接受經導管主動脈瓣置換術 (TAVR) 的情況下。正在進行的臨床試驗正在評估瓣膜壽命、瓣膜結構劣化和血栓形成性，以促進其長期應用。基於聚合物的瓣葉設計、組織工程支架和抗血栓塗層正在被研究，以延長瓣膜壽命，突破現有生物瓣膜的限制。同時，標準化瓣中瓣手術、最佳化小瓣環內的血流動力學以及減少對心律調節器的依賴等努力，正在推動器械發展的下一個前沿。

哪些患者族群和地理市場正在推動主動脈瓣介入治療的需求？

主動脈瓣置換術的主要動力是患有症狀性嚴重主動脈瓣狹窄的老年患者，尤其是在北美和西歐，這些地區的診斷途徑、手術基礎設施和報銷模式都已完善。然而，隨著心臟超音波圖的篩檢應用以及對心臟瓣膜疾病認知的提高，無症狀性和中危險群的轉診量正在擴大。對於體弱患者、先前接受心血管手術的患者以及解剖結構複雜、導致開胸手術風險增加的患者，經導管主動脈瓣置換術 (TAVR) 越來越受到青睞。

年輕患者和雙尖瓣患者正成為關注的焦點，尤其是在平均診斷年齡較低且報銷限制使SAVR成為預設選項的市場。此外，隨著第一波組織瓣膜植入開始消退，瓣中瓣領域正在蓬勃發展。這為TAVR修復手術帶來了新的需求，而越來越多的證據表明其在再介入中的安全性和有效性。

從地區來看，北美佔據最大市場佔有率，其次是歐洲，這得益於其高手術量、先進的醫療基礎設施和成熟的培訓生態系統。亞太地區是成長最快的地區，這得益於醫療保健涵蓋範圍的擴大、人們對心臟瓣膜疾病認知的不斷提高，以及中國、印度、日本和東南亞地區私人心血管中心的快速發展。同時，拉丁美洲以及中東和非洲部分地區的應用也受到官民合作關係、醫療旅遊以及三級心血管護理基礎設施投資增加的支持。

新興市場在法規、以價值為基礎的照護模式和臨床證據方面的發展如何影響市場成長？

主動脈瓣膜裝置的監管格局正在迅速演變，各機構透過優先審查、突破性療法認定以及依賴全球臨床數據，加速TAVR系統的核准途徑。 FDA和EMA等機構正在將器械適應症從高風險患者擴展到中度風險和低風險患者，從而擴大手術合格和保險覆蓋範圍。上市後監測和註冊系統（例如美國的TVT和歐洲的NOTION）正在提供長期療效數據，以支援持續的報銷和納入指南。

隨著醫療保健系統逐漸採用基於價值的模式，成本效益和生活品質的提升已成為技術應用的關鍵。大量健康經濟學研究表明，儘管TAVR的前期成本較高，但它透過降低再入院率、改善功能預後以及降低目標族群的死亡率，提供了長期價值。醫院擴大根據手術成功率、再次干預風險以及與多學科心臟團隊不斷發展的治療方案的兼容性來選擇瓣膜平台。

歐洲外科學會 (ESC)、美國心臟協會 (AHA)/美國心臟協會 (ACC) 和美國外科學會 (JCS) 等學會的臨床指南正在將 TAVR 納入針對更廣泛患者群體的關鍵建議中。同時，全球培訓工作和跨境知識交流也促進了從業人員的熟練程度和護理標準化。隨著療效的改善以及相關人員對數據驅動決策的需求，臨床證據仍將是市場成長和器械製造商策略差異化的關鍵。

哪些因素推動了主動脈瓣市場的成長？

主動脈瓣市場正經歷強勁成長，這得益於全球瓣膜性心臟病發病率的上升、微創介入治療覆蓋範圍的擴大，以及以患者為中心、循證循環系統治療的持續轉變。主要促進因素包括人口老化、篩檢增加、治療指南的不斷演變，以及經導管主動脈瓣置換術 (TAVR) 在年輕和低風險族群的廣泛應用。從外科手術到導管治療的轉變，在手術量和可及性方面具有特別顯著的轉變。

隨著相關人員尋求個人化、數據主導的治療途徑，技術差異化、長期耐用性和臨床多功能性已成為市場競爭力的關鍵。同時，對混合手術室、專業心臟瓣膜中心以及接受過先進瓣膜療法培訓的跨職能心血管團隊的持續投資也為市場擴張提供了支持。隨著全球醫療保健系統優先考慮高效、微創和高價值的治療，主動脈瓣技術正逐漸成為結構性心臟病管理的重要工具。

主動脈瓣市場未來的發展方向將取決於下一代設備如何在不同的醫療環境中有效平衡性能、耐用性和價格。隨著精準心臟病學與微創技術的融合，主動脈瓣能否成為全球轉型為預防性和恢復性心臟照護的核心節點？

部分

瓣膜類型（機械、生物）、最終用途（醫院、門診手術中心、其他最終用途）

調查企業範例（共34家企業）

  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • Artivion Inc.
  • AutoTissue GmbH
  • Boston Scientific Corporation
  • CarboMedics Inc.
  • Cardiac Dimensions Inc.
  • Cardiosolutions Inc.
  • Corcym Inc.
  • CryoLife Inc.
  • Edwards Lifesciences
  • Endovalve Inc.
  • Foldax Inc.
  • JenaValve Technology Inc.
  • Leman Cardiovascular
  • LivaNova PLC
  • Medtentia AB
  • Medtronic Plc
  • MiCardia Corporation
  • MitralSolutions Inc.

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）來預測其競爭地位的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP34610

Global Aortic Valves Market to Reach US$9.8 Billion by 2030

The global market for Aortic Valves estimated at US$6.1 Billion in the year 2024, is expected to reach US$9.8 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Mechanical Valves, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Biological Valves segment is estimated at 10.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 12.6% CAGR

The Aortic Valves market in the U.S. is estimated at US$1.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 12.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global Aortic Valves Market - Key Trends & Drivers Summarized

Why Are Aortic Valves Central to the Management of Structural Heart Disease in Aging Populations?

Aortic valves play a vital role in regulating unidirectional blood flow from the left ventricle to the aorta, and their dysfunction-typically stenosis or regurgitation-leads to significant cardiac morbidity and mortality. Aortic valve replacement (AVR), through either surgical or transcatheter approaches, has become a cornerstone intervention in structural heart disease, particularly among elderly patients with degenerative valve conditions. With the global burden of aortic stenosis rising in parallel with aging demographics, aortic valves are increasingly viewed as life-saving implants for restoring cardiac function, relieving symptoms, and improving survival rates.

Historically, surgical aortic valve replacement (SAVR) was the standard of care, requiring open-heart surgery with cardiopulmonary bypass. However, the advent of transcatheter aortic valve replacement (TAVR)-a minimally invasive approach-has transformed treatment paradigms, expanding access to patients previously deemed inoperable or high-risk for surgery. TAVR’s use has since expanded to intermediate and low-risk groups, reinforcing its role as a first-line therapy across broader patient cohorts. This shift is being fueled by favorable clinical trial data demonstrating comparable or superior outcomes relative to SAVR in appropriate candidates.

Beyond stenosis, aortic valve interventions are gaining ground in the management of bicuspid valve disease, valve-in-valve procedures for degenerated bioprostheses, and combined valvular pathologies requiring multi-valve interventions. The growing prevalence of heart failure, calcific valve degeneration, and increased screening in asymptomatic patients is further driving procedural volume. As life expectancy increases and cardiovascular disease remains a global health priority, aortic valve replacement continues to serve as a critical intervention in contemporary cardiology.

How Are Device Innovations and Procedural Technologies Enhancing Valve Performance and Patient Outcomes?

Innovations in valve design are improving hemodynamic performance, durability, and implantability of both surgical and transcatheter aortic valves. Bioprosthetic valves-constructed from bovine or porcine pericardial tissue-are now treated with anti-calcification agents and mounted on flexible frames to reduce immune response and extend lifespan. New-generation TAVR systems offer repositionable and retrievable features, lower-profile delivery catheters, and enhanced radial strength for secure anchoring, even in anatomically challenging cases such as severely calcified or bicuspid aortic roots.

Advancements in pre-procedural imaging, especially multidetector CT and 3D echocardiography, have enabled more precise patient selection, annular sizing, and procedural planning. Integration of imaging with digital navigation platforms and real-time fluoroscopic guidance has minimized paravalvular leak, vascular injury, and conduction disturbances. In addition, intraprocedural innovations such as cerebral embolic protection devices and conscious sedation protocols are improving safety profiles and enabling shorter recovery times.

Durability remains a central focus of innovation, particularly as younger and lower-risk patients undergo TAVR. Ongoing trials are assessing leaflet longevity, structural valve deterioration, and thrombogenicity to support long-term adoption. Polymer-based leaflet designs, tissue-engineered scaffolds, and anti-thrombotic coatings are being explored to extend valve life beyond current bioprosthetic limits. Meanwhile, efforts to standardize valve-in-valve procedures, optimize hemodynamics in small annuli, and reduce pacemaker dependency are pushing the next frontier in device evolution.

Which Patient Segments and Regional Markets Are Fueling Demand for Aortic Valve Interventions?

The primary drivers of aortic valve replacement remain elderly patients with symptomatic severe aortic stenosis, particularly in North America and Western Europe where diagnostic access, procedural infrastructure, and reimbursement models are well-established. However, the increasing use of echocardiographic screening and growing awareness of heart valve disease are expanding referrals even among asymptomatic patients and moderate-risk groups. TAVR is increasingly preferred for frail patients, those with prior cardiac surgery, and those with anatomical complexities that increase open-surgery risk.

Younger patients and those with bicuspid valves are emerging as an important focus, particularly in markets where average age at diagnosis is lower or where SAVR remains the default due to reimbursement constraints. The valve-in-valve segment is also growing rapidly as the first wave of bioprosthetic implants begins to degenerate. This is creating a new layer of demand for redo TAVR procedures, supported by growing evidence of safety and efficacy in reinterventions.

Geographically, North America holds the largest market share, followed by Europe, driven by high procedural volumes, advanced healthcare infrastructure, and established training ecosystems. Asia-Pacific represents the fastest-growing region due to expanding healthcare access, increasing awareness of valvular heart disease, and rapid growth in private cardiovascular centers across China, India, Japan, and Southeast Asia. Meanwhile, adoption in Latin America, the Middle East, and parts of Africa is supported by public-private partnerships, medical tourism, and growing investment in tertiary cardiovascular care infrastructure.

How Are Regulatory Developments, Value-Based Care Models, and Clinical Evidence Influencing Market Expansion?

The regulatory landscape for aortic valve devices is evolving rapidly, with authorities accelerating approval pathways for TAVR systems through priority review, breakthrough designation, and reliance on global clinical data. Agencies such as the FDA and EMA have expanded device indications from high-risk to intermediate- and low-risk patients, driving broader procedural eligibility and insurance coverage. Post-market surveillance and registries-such as TVT in the U.S. and NOTION in Europe-are providing long-term outcomes data that support ongoing reimbursement and guideline inclusion.

As healthcare systems adopt value-based models, cost-effectiveness and quality-of-life improvements are becoming pivotal to technology adoption. Numerous health economic studies have shown that TAVR, despite higher upfront costs, offers long-term value through reduced rehospitalization, improved functional outcomes, and lower mortality in eligible populations. Hospitals are increasingly selecting valve platforms based on procedure success rates, reintervention risk, and compatibility with evolving treatment protocols across multi-disciplinary heart teams.

Clinical guidelines from societies such as the ESC, AHA/ACC, and JCS are incorporating TAVR into mainstream recommendations for a broader patient population. Simultaneously, global training initiatives and cross-border knowledge exchange are supporting operator proficiency and standardization of care. As procedural outcomes improve and stakeholders demand data-backed decision-making, clinical evidence will remain a cornerstone of market growth and strategic differentiation among device manufacturers.

What Are the Factors Driving Growth in the Aortic Valves Market?

The aortic valves market is experiencing robust growth, fueled by the global rise in valvular heart disease, expanded eligibility for minimally invasive interventions, and the continuous shift toward patient-centered, evidence-based cardiovascular care. Key drivers include aging populations, increased screening, evolving treatment guidelines, and growing comfort with TAVR in younger and lower-risk cohorts. The transition from surgical to catheter-based interventions is particularly transformative in terms of procedural volume and accessibility.

Technological differentiation, long-term durability, and clinical versatility are becoming critical to market competitiveness as stakeholders demand personalized, data-driven care pathways. Meanwhile, market expansion is supported by rising investment in hybrid ORs, specialized heart valve centers, and cross-functional cardiovascular teams trained in advanced valve therapies. As global health systems prioritize efficient, minimally invasive, and high-value care, aortic valve technologies are emerging as essential tools in structural heart disease management.

Looking forward, the evolution of the aortic valves market will depend on how effectively the next generation of devices balances performance, durability, and affordability across diverse healthcare settings. As precision cardiology converges with minimally invasive technologies, could aortic valves represent the central node of a global shift toward preventative and restorative heart care?

SCOPE OF STUDY:

The report analyzes the Aortic Valves market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Valve Type (Mechanical Valves, Biological Valves); End-Use (Hospitals, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • Artivion Inc.
  • AutoTissue GmbH
  • Boston Scientific Corporation
  • CarboMedics Inc.
  • Cardiac Dimensions Inc.
  • Cardiosolutions Inc.
  • Corcym Inc.
  • CryoLife Inc.
  • Edwards Lifesciences
  • Endovalve Inc.
  • Foldax Inc.
  • JenaValve Technology Inc.
  • Leman Cardiovascular
  • LivaNova PLC
  • Medtentia AB
  • Medtronic Plc
  • MiCardia Corporation
  • MitralSolutions Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Aortic Valves - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Aortic Stenosis and Valve Disease Throws the Spotlight on Aortic Valve Replacement
    • Growth in Transcatheter Aortic Valve Replacement (TAVR) Procedures Spurs Minimally Invasive Treatment Demand
    • OEM Innovations in Tissue-Engineered and Self-Expanding Valves Strengthen Market Penetration
    • Increasing Use of Bioprosthetic Valves in Aging Populations Supports Shift Away From Mechanical Alternatives
    • Expansion of Valve-in-Valve Procedures Bodes Well for TAVR in Failed Surgical Valve Replacements
    • Advancements in Imaging-Guided Implantation Improve Procedural Accuracy and Clinical Outcomes
    • Growth in Aortic Valve Clinics and Multidisciplinary Heart Teams Enhances Patient Selection and Preoperative Planning
    • Rise in Early Intervention Guidelines and Lower-Risk Patient Approvals Accelerates Market Growth
    • Integration of AI and Predictive Modeling Supports Personalized Valve Selection and Post-Procedure Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Aortic Valves Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Aortic Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Mechanical Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Mechanical Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Mechanical Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biological Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biological Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Biological Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Aortic Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Aortic Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Aortic Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Aortic Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Aortic Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Aortic Valves by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Aortic Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Aortic Valves by Valve Type - Mechanical Valves and Biological Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Aortic Valves by Valve Type - Percentage Breakdown of Value Sales for Mechanical Valves and Biological Valves for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Aortic Valves by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Aortic Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION